It was 1959 when the Nobel Prize-winning physicist Richard P. Feynman suggested the immense possibilities afforded by miniaturization. Since then the use of nanoparticles has increased significantly in several fields, among which diagnostics, biomedicine, environmental remediation, and water treatment, generating great expectations. The combination of nanotechnologies and medicine radically increased the possibilities in both life sciences and healthcare providing, day by day, new and surprising solutions.
Thanks to the possibility to synthesize various kind of nanoparticles (amongst other silica, magnetic, polymeric) and the ability to control their size, to modify surface characteristics and conjugate them with biological entities as antibodies, oligonucleotides and drugs (just to name a few), AcZon’s fluorescent silica nanoparticles are considered a dramatically versatile tool which allows a multitude of applications.
NanoChromes and NanoTandems for immunofluorescence, NanoLisa & NanoLisa-F for colorimetric detection using enzymatic reaction, NanoRad for imaging and NanoCarrier for future applications in therapy are just an example of the possible declinations of the technology internally developed in AcZon.